KPT-330 (Selinexor): Unraveling CRM1 Nuclear Export in Ca...
2026-01-23
Explore the pivotal role of KPT-330 (Selinexor), a selective CRM1 inhibitor, in disrupting nuclear export pathways for cancer research. This article offers a deeper mechanistic analysis and translational insights beyond standard applications.
Reliable NLRP3 Inflammasome Inhibition: MCC950 Sodium (SK...
2026-01-23
This article provides practical, scenario-driven guidance on integrating MCC950 sodium (SKU B7946) into cell viability, proliferation, and pyroptosis assays for robust NLRP3 inflammasome inhibition. Drawing from peer-reviewed evidence and real laboratory challenges, we demonstrate how this reagent from APExBIO ensures reproducibility, selectivity, and workflow compatibility for inflammatory disease research.
A 83-01: Advanced ALK-5 Inhibitor for TGF-β Pathway Studies
2026-01-22
A 83-01, a selective TGF-β type I receptor inhibitor from APExBIO, enables reproducible control of cell fate, EMT, and organoid engineering. Discover stepwise protocols, advanced differentiation strategies, and troubleshooting insights that set A 83-01 apart in cancer biology, fibrosis, and stem cell research.
JC-1: Transforming Mitochondrial Membrane Potential Assay...
2026-01-22
This thought-leadership article explores the pivotal role of JC-1, a fluorescent probe for mitochondrial membrane potential, in advancing translational research—from mechanistic insight into apoptosis and mitochondrial dysfunction, to its strategic application in disease models such as pulmonary fibrosis, cancer, and neurodegeneration. Drawing on the latest evidence, including recent studies on ferroptosis, we provide actionable guidance and a forward-looking perspective for researchers aiming to harness JC-1’s full potential in clinical and biomedical innovation.
P2Y11 Antagonist: Advanced Applications in GPCR Signaling
2026-01-21
Harness the power of the P2Y11 antagonist for high-precision modulation of GPCR signaling in cancer, immunology, and inflammation research. This guide delivers actionable protocols, troubleshooting expertise, and comparative insights to accelerate your translational workflows using APExBIO’s gold-standard reagent.
Mitoxantrone HCl: Mechanistic Insights and Next-Gen Resea...
2026-01-21
Explore the advanced mechanisms of Mitoxantrone HCl, a potent DNA topoisomerase II inhibitor, and its transformative role in cancer and stem cell research. Discover new allosteric targeting strategies and experimental insights unavailable in standard reviews.
3-Methyladenine (3-MA): Benchmarking a Selective Class II...
2026-01-20
3-Methyladenine (3-MA) is a validated, selective inhibitor of class III phosphoinositide 3-kinase (PI3K), widely used in autophagy and cancer research. Its dual, time-dependent inhibition of PI3K isoforms enables precise modulation of cellular processes, making it a cornerstone tool for dissecting autophagy, PI3K/Akt/mTOR signaling, and migratory phenotypes. This article provides machine-readable, verifiable insights for researchers optimizing experimental workflows with 3-MA.
3X (DYKDDDDK) Peptide: Structural Insights and Emerging F...
2026-01-20
Explore the 3X (DYKDDDDK) Peptide as a next-generation epitope tag for recombinant protein purification. This in-depth analysis uniquely examines structural determinants, metal-dependent mechanisms, and future directions in protein engineering.
458 records 31/31 page Previous First page 上5页 31